Friday, November 04, 2022 9:52:58 PM
Yet it literally says it's for acquiring third party IPR&D. Sorry if thats inconvienent.
Now why do you ignore that fact that a third party company submitted a Si3N4 related arthroplasty device to a regulatory agency? Its not Sintx that submitted it. That means its either Zimmer utilizing Sintx MC2 femoral head or a different company working on Si3N4 femoral head. Based on the information in Sintx 10k only MC2 could be submitted via a 510k as its substantially equivalent to Biolox Delta. The coating they are working on would require PMA if I understood it correctly. But Sintx isnt submitting a hip implant so that means a partner is required.
If Zimmer submitted, as evidence suggests, then the submission is based on Sonnys design at Missouri S&T. Payment for that IP would be required. It makes sense for Zimer to have acquired the IP in 2017 after femoral head testing was complete. It could then take over the project from there.
Now why do you ignore that fact that a third party company submitted a Si3N4 related arthroplasty device to a regulatory agency? Its not Sintx that submitted it. That means its either Zimmer utilizing Sintx MC2 femoral head or a different company working on Si3N4 femoral head. Based on the information in Sintx 10k only MC2 could be submitted via a 510k as its substantially equivalent to Biolox Delta. The coating they are working on would require PMA if I understood it correctly. But Sintx isnt submitting a hip implant so that means a partner is required.
If Zimmer submitted, as evidence suggests, then the submission is based on Sonnys design at Missouri S&T. Payment for that IP would be required. It makes sense for Zimer to have acquired the IP in 2017 after femoral head testing was complete. It could then take over the project from there.
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 07:00:23 PM
- SINTX Technologies to Present at the LD Micro Invitational XVI Conference • Newsfile • 05/17/2026 07:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
